HLA-DRA and neoplasm: AR was expressed in a median of 32.9% of CD163 and/or HLA-DRA and/or CD14 expressing cells in the Tumour area, which was not significantly different from cells in the tumour border or in the distant area (median 34.2% and 35.2%, respectively) (Fig. 1d).